Triamcinolone Hexacetonide Injection Shortage
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
FDA reports current shortage of Triamcinolone Hexacetonide Injection from Medexus due to shipping delay, with no estimated recovery date.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on June 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Triamcinolone Hexacetonide.
What's in Shortage
Triamcinolone Hexacetonide Injection (dosage form: Injection), therapeutic category: Rheumatology. Status: Current. Initial posting date: 05/04/2021. Last updated: 05/27/2026.
Which Manufacturers Are Affected
- Medexus: Unavailable. Presentation: Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01). Estimated recovery: TBD. Contact: 1-855-336-3322 Option 9.
Why There's a Shortage
Delay in shipping of the drug.
What Patients Should Do
Patients should talk to their pharmacist, ask about alternatives if appropriate, and contact the manufacturer for current availability. Always consult your healthcare provider for personalized advice. Do not make changes to medication without professional guidance.
Source
FDA Drug Shortage Database
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (784 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to June 6, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.